Afficher la couverture 'Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial | Bidard, François-Clément' en grand format
/5

0 avis

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

Archive ouverte

Bidard, François-Clément | Hardy-Bessard, Anne-Claire | Dalenc, Florence | Bachelot, Thomas | Pierga, Jean-Yves | de la Motte Rouge, Thibault | Sabatier, Renaud | Dubot, Coraline | Frenel, Jean-Sébastien | Ferrero, Jean Marc | Ladoire, Sylvain | Levy, Christelle | Mouret-Reynier, Marie-Ange | Lortholary, Alain | Grenier, Julien | Chakiba, Camille | Stefani, Laetitia | Plaza, Jérôme Edouard | Clatot, Florian | Teixeira, Luis | d'Hondt, Véronique | Vegas, Hélène | Derbel, Olfa | Garnier-Tixidre, Claire | Canon, Jean-Luc | Pistilli, Barbara | André, Fabrice | Arnould, Laurent | Pradines, Anne | Bièche, Ivan | Callens, Céline | Lemonnier, Jérôme | Berger, Frédérique | Delaloge, Suzette | Bidard, Francois-Clement | Ferrero, Jean-Marc | Soulie, Patrick | Jacquin, Jean-Philippe | Garnier Tixidre, Claire | Delbaldo, Catherine | Moreau, Lionel | Cheneau, Caroline | Paitel, Jean-François | Bernard-Marty, Chantal | Spaeth, Dominique | Genet, Dominique | Moullet, Isabelle | Bonichon-Lamichhane, Nathalie | Deiana, Laura | Greilsamer, Charlotte | Venat-Bouvet, Laurence | Delecroix, Valérie | Melis, Adrien | Orfeuvre, Hubert | Nguyen, Suzanne | Legouffe, Eric | Zannetti, Alain | Le Scodan, Romuald | Dohollou, Nadine | Dalivoust, Philippe | Arsene, Olivier | Marques, Nathalie | Petit, Thierry | Mollon, Delphine | Dauba, Jérôme | Bonnin, Nathalie | Morvan, François | Gardner, Miriam | Marti, Adina | Levache, Charles-Briac | Lachaier, Emma | Achille, Mihaela | Valmar, Christophe | Bouaita, Ryan | Medioni, Jacques | Foa, Cyril | del Piano, Francesco | Gozy, Michel | Escande, Anne | Leduc, Nicolas | Lucas, Brigitte | Mille, Dominique | Ammarguellat, Hanifa | Najem, Abeer | Trouboul, Fanny | Barthelemy, Philippe | Desclos, Hervé | Mayeur, Didier | Lorchel, Fabrice | Guinet, François | Laurenty, Anne-Pascale | Boudrant, Axelle | Gisserot, Olivier | Alleaume, Corinne | de Gramont, Aimery

Edité par CCSD ; Elsevier -

International audience

Consulter en ligne

Suggestions

Du même auteur

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

Archive ouverte | Bidard, François-Clément | CCSD

International audience

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1

Archive ouverte | Berger, Frédérique | CCSD

International audience. Introduction The combination of a CDK4/6 inhibitor with an aromatase inhibitor (AI) has recently become the gold standard for AI-sensitive first line treatment of oestrogen receptor-positive ...

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study

Archive ouverte | Bertucci, François | CCSD

International audience

Chargement des enrichissements...